We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+0.07%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$14.3B
AUM Growth
-$743M
Cap. Flow
-$494M
Cap. Flow %
-3.46%
Top 10 Hldgs %
8.41%
Holding
1,329
New
83
Increased
398
Reduced
492
Closed
75

Top Sells

Rank Stock Value
1
MKSI icon
MKS Inc
MKSI
+$35.5M
2
WWD icon
Woodward
WWD
+$35M
3
CPRT icon
Copart
CPRT
+$22.9M
4
BGC
General Cable Corporation
BGC
+$22.7M
5
ORBK
Orbotech Ltd
ORBK
+$22.1M

Sector Composition

Rank Sector Weight
1 Industrials 28.26%
2 Technology 16.98%
3 Consumer Discretionary 14.15%
4 Financials 11.65%
5 Materials 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVLT
651
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
$3.79M 0.03%
1,105,454
-269,200
-20% -$983K
EMR icon
652
Emerson Electric
EMR
$83.6B
$3.79M 0.03%
55,500
-11,000
-17% -$783K
NSP icon
653
Insperity
NSP
$1.92B
$3.76M 0.03%
54,022
APEI icon
654
American Public Education
APEI
$907M
$3.75M 0.03%
87,296
-28,657
-25% -$879K
FRC
655
DELISTED
First Republic Bank
FRC
$3.74M 0.03%
40,400
AMTD
656
DELISTED
TD Ameritrade Holding Corp
AMTD
$3.73M 0.03%
62,980
-5,800
-8% -$329K
PHX
657
DELISTED
PHX Minerals
PHX
$3.72M 0.03%
192,700
-21,300
-10% -$421K
CALY
658
Callaway Golf Company
CALY
$3.28B
$3.7M 0.03%
226,000
-26,000
-10% -$396K
ABTX
659
DELISTED
Allegiance Bancshares
ABTX
$3.69M 0.03%
94,300
+36,300
+63% +$1.43M
EGRX
660
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3.69M 0.03%
70,043
-21,291
-23% -$1.24M
LEG icon
661
Leggett & Platt
LEG
$1.5B
$3.68M 0.03%
83,000
-16,500
-17% -$757K
GNSS icon
662
Genasys
GNSS
$74.2M
$3.68M 0.03%
1,598,400
IPI icon
663
Intrepid Potash
IPI
$461M
$3.66M 0.03%
100,596
+24,400
+32% +$944K
EVI icon
664
EVI Industries
EVI
$183M
$3.65M 0.03%
93,100
PATI
665
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
$3.62M 0.03%
194,864
EBIX
666
DELISTED
Ebix Inc
EBIX
$3.6M 0.03%
48,316
ON icon
667
ON Semiconductor
ON
$34.7B
$3.6M 0.03%
147,000
ASPN icon
668
Aspen Aerogels
ASPN
$385M
$3.58M 0.03%
839,642
+138,234
+20% +$654K
CLAR icon
669
Clarus
CLAR
$126M
$3.56M 0.02%
529,604
-233,627
-31% -$1.66M
SRGA
670
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$3.54M 0.02%
25,679
+4,740
+23% +$645K
CBM
671
DELISTED
Cambrex Corporation
CBM
$3.54M 0.02%
67,768
-21,743
-24% -$1.16M
LILAK icon
672
Liberty Latin America Class C
LILAK
$1.55B
$3.52M 0.02%
215,709
+19,275
+10% +$355K
RSPP
673
DELISTED
RSP Permian, Inc.
RSPP
$3.52M 0.02%
75,000
-107,000
-59% -$4.21M
VFC icon
674
VF Corp
VFC
$6.72B
$3.51M 0.02%
50,339
-55,861
-53% -$4.04M
HBB icon
675
Hamilton Beach Brands
HBB
$300M
$3.51M 0.02%
165,484
+31,135
+23% +$773K

Similar funds

Royce & Associates's Q1 2018 Portfolio in Review

As of Q1 2018, Royce & Associates held 1,329 positions worth $14.3B, down 4.9% from $15B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

Royce & Associates withdrew a net $494M in Q1 2018, closing 75 positions and reducing 492 holdings. Its most notable exit was Sucampo Pharmaceuticals, Inc., an estimated $15.8M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in PotlatchDeltic worth $12M.

  • Royce & Associates's largest Q1 2018 buy was PotlatchDeltic: 230,008 shares worth $12M.
  • Royce & Associates added most to Core Mark Holding Co., Inc. in Q1 2018, an estimated $24M increase.
  • Royce & Associates's biggest Q1 2018 reduction was MKS Inc, cutting an estimated $35.5M.
  • Royce & Associates fully exited Sucampo Pharmaceuticals, Inc. in Q1 2018, selling an estimated $15.8M.
  • Royce & Associates's ten largest holdings make up 8.4% of its $14.3B portfolio in Q1 2018.
  • Royce & Associates opened 83 new positions and closed 75 in Q1 2018.
  • Royce & Associates's portfolio value fell 4.9% quarter-over-quarter to $14.3B.

Based on Royce & Associates's 13F filing for Q1 2018, filed 14 May 2018.